Scarica l'app Stockscreener
35.98
26.02%
7.43
Dopo l'orario di chiusura:
35.74
-0.24
-0.67%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$28.55
Aprire:
$32.83
Volume 24 ore:
3.49M
Relative Volume:
1.69
Capitalizzazione di mercato:
$684.29M
Reddito:
$90.12M
Utile/perdita netta:
$-276.06M
Rapporto P/E:
-24.64
EPS:
-1.46
Flusso di cassa netto:
$-193.47M
1 W Prestazione:
+22.63%
1M Prestazione:
+54.62%
6M Prestazione:
+4,164%
1 anno Prestazione:
+2,802%
Intervallo 1D:
$31.85
$36.38
Intervallo di 1 settimana:
$27.87
$36.38
Portata 52W:
$0.432
$37.38
Nektar Therapeutics Stock (NKTR) Company Profile
Nome
Nektar Therapeutics
Settore
Industria
Telefono
(415) 482-5300
Indirizzo
455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA
Confronta NKTR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NKTR
Nektar Therapeutics
|
35.98 | 553.16M | 90.12M | -276.06M | -193.47M | -1.46 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Nektar Therapeutics Stock (NKTR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-24 | Reiterato | BTIG Research | Buy |
| 2025-06-24 | Reiterato | H.C. Wainwright | Buy |
| 2025-04-11 | Aggiornamento | Jefferies | Hold → Buy |
| 2025-03-14 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2025-01-08 | Iniziato | B. Riley Securities | Buy |
| 2024-12-10 | Iniziato | H.C. Wainwright | Buy |
| 2024-11-04 | Iniziato | Piper Sandler | Overweight |
| 2024-09-30 | Ripresa | BTIG Research | Buy |
| 2024-06-28 | Iniziato | Rodman & Renshaw | Buy |
| 2023-11-20 | Ripresa | JP Morgan | Underweight |
| 2023-11-09 | Aggiornamento | TD Cowen | Market Perform → Outperform |
| 2023-05-10 | Aggiornamento | Jefferies | Underperform → Hold |
| 2023-02-24 | Downgrade | Jefferies | Hold → Underperform |
| 2022-08-08 | Downgrade | JP Morgan | Neutral → Underweight |
| 2022-05-31 | Ripresa | Jefferies | Hold |
| 2022-04-18 | Downgrade | Goldman | Neutral → Sell |
| 2022-03-15 | Downgrade | Cowen | Outperform → Market Perform |
| 2022-03-15 | Downgrade | Mizuho | Buy → Neutral |
| 2022-03-14 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-03-14 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-03-14 | Downgrade | Stifel | Buy → Hold |
| 2022-03-14 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2022-03-09 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2021-11-08 | Aggiornamento | The Benchmark Company | Hold → Buy |
| 2021-09-10 | Iniziato | BofA Securities | Neutral |
| 2021-06-28 | Aggiornamento | Stifel | Hold → Buy |
| 2021-05-18 | Ripresa | Goldman | Neutral |
| 2021-02-22 | Downgrade | The Benchmark Company | Buy → Hold |
| 2021-01-06 | Iniziato | Stifel | Hold |
| 2020-09-14 | Iniziato | JP Morgan | Neutral |
| 2020-06-10 | Downgrade | CFRA | Hold → Sell |
| 2020-05-12 | Reiterato | H.C. Wainwright | Neutral |
| 2020-04-22 | Iniziato | The Benchmark Company | Buy |
| 2020-03-30 | Aggiornamento | Goldman | Sell → Neutral |
| 2020-03-04 | Iniziato | Barclays | Overweight |
| 2020-02-03 | Aggiornamento | Mizuho | Neutral → Buy |
| 2019-10-24 | Iniziato | Oppenheimer | Perform |
| 2019-10-08 | Downgrade | Goldman | Buy → Sell |
| 2019-08-09 | Downgrade | JP Morgan | Overweight → Neutral |
| 2019-08-09 | Downgrade | Jefferies | Buy → Hold |
| 2019-08-09 | Downgrade | Mizuho | Buy → Neutral |
| 2019-03-15 | Iniziato | SVB Leerink | Mkt Perform |
| 2018-12-13 | Iniziato | Goldman | Buy |
| 2018-06-11 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2018-06-04 | Reiterato | H.C. Wainwright | Buy |
| 2018-04-20 | Iniziato | Seaport Global Securities | Buy |
| 2018-04-13 | Ripresa | Piper Jaffray | Overweight |
| 2018-04-06 | Reiterato | Mizuho | Buy |
| 2018-04-02 | Ripresa | H.C. Wainwright | Buy |
Mostra tutto
Nektar Therapeutics Borsa (NKTR) Ultime notizie
Nektar Therapeutics’ Strategic Investor Engagement and Pipeline Progress - AInvest
Nektar Therapeutics to Participate in Two Investor Conferences in September - StreetInsider
Biotech Leader Nektar Therapeutics Set for Double Investor Conference Appearances in September 2025 - Stock Titan
Will Nektar Therapeutics outperform the market in YEARProduct Launch & Safe Entry Momentum Tips - khodrobank.com
Published on: 2025-09-03 09:08:30 - Newser
Using fundamentals and technicals on Nektar Therapeutics2025 Volatility Report & Community Shared Stock Ideas - Newser
Nektar Therapeutics stock trend outlook and recovery path2025 AllTime Highs & Reliable Trade Execution Plans - Newser
Will Nektar Therapeutics announce a stock splitQuarterly Risk Review & Reliable Intraday Trade Plans - khodrobank.com
How to manage a losing position in Nektar TherapeuticsQuarterly Trade Report & Low Volatility Stock Recommendations - Newser
Should you wait for a breakout in Nektar TherapeuticsWeekly Profit Recap & Free Safe Entry Trade Signal Reports - Newser
Real time alert setup for Nektar Therapeutics performance2025 Major Catalysts & Growth Focused Entry Reports - Newser
Comparing Nektar Therapeutics in custom built stock radarsWeekly Market Summary & Momentum Based Trading Ideas - Newser
Multi asset correlation models including Nektar TherapeuticsJuly 2025 Volume & Smart Allocation Stock Reports - Newser
Nektar Therapeutics stock outlook for YEARJuly 2025 PreEarnings & Fast Entry High Yield Tips - Newser
Is Nektar Therapeutics stock ready for a breakout2025 Momentum Check & Expert Curated Trade Setup Alerts - Newser
What does recent volatility data suggest for Nektar Therapeutics2025 Market WrapUp & Community Trade Idea Sharing - Newser
How to monitor Nektar Therapeutics with trend dashboardsMarket Volume Summary & Fast Exit and Entry Strategy Plans - Newser
Automated trading signals detected on Nektar TherapeuticsPortfolio Value Summary & Daily Stock Trend Watchlist - Newser
Combining machine learning predictions for Nektar TherapeuticsWeekly Risk Report & Weekly Top Gainers Trade List - Newser
Can Nektar Therapeutics recover in the next quarterProfit Target & AI Forecasted Stock Moves - Newser
Will Nektar Therapeutics benefit from macro trendsJuly 2025 Momentum & Expert Curated Trade Setup Alerts - Newser
how to manage a losing position in nektar therapeuticsEarnings Performance Report & Risk Controlled Stock Pick Alerts - Newser
Nektar Therapeutics stock volume spike explained2025 Performance Recap & Community Verified Watchlist Alerts - Newser
How to interpret RSI for Nektar Therapeutics stock2025 Major Catalysts & Reliable Entry Point Trade Alerts - Newser
Can Nektar Therapeutics continue delivering strong returnsJuly 2025 News Drivers & Weekly Sector Rotation Insights - khodrobank.com
Can momentum traders help lift Nektar TherapeuticsBuy Signal & Community Verified Trade Alerts - Newser
Applying big data sentiment scoring on Nektar Therapeutics2025 Top Gainers & Daily Oversold Bounce Ideas - Newser
What MACD signals say about Nektar TherapeuticsWeekly Market Outlook & Accurate Technical Buy Alerts - Newser
Is Nektar Therapeutics stock trending bullishWeekly Trade Summary & Real-Time Stock Price Movement Reports - khodrobank.com
What indicators show strength in Nektar TherapeuticsTrade Risk Report & Daily Price Action Insights - Newser
Why Nektar Therapeutics stock attracts strong analyst attentionCEO Change & Consistent Profit Trade Alerts - Newser
Colorectal Cancer Pipeline Outlook 2025 – Clinical Trials, Medication, Therapies, Companies by DelveInsight - Barchart.com
Measuring Nektar Therapeutics’s beta against major indicesQuarterly Earnings Report & Free Fast Gain Swing Trade Alerts - Newser
Candlestick signals on Nektar Therapeutics stock todayJuly 2025 Technicals & Verified Momentum Stock Alerts - Newser
How to build a custom watchlist for Nektar TherapeuticsRate Hike & Weekly Watchlist of Top Performers - Newser
How to use a screener to detect Nektar Therapeutics breakouts2025 Technical Patterns & Long-Term Growth Portfolio Plans - Newser
Using data models to predict Nektar Therapeutics stock movement2025 Big Picture & Real-Time Stock Entry Alerts - Newser
Signal strength of Nektar Therapeutics stock in tech scanners2025 Pullback Review & AI Forecasted Entry/Exit Points - Newser
Nektar Therapeutics Azioni (NKTR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.75%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):